Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Low-efficacy HIV vaccines: potential for community-based intervention programmes.

Anderson RM, Garnett GP.

Lancet. 1996 Oct 12;348(9033):1010-3.

PMID:
8855867
2.

The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results.

Andersson KM, Paltiel AD, Owens DK.

Vaccine. 2011 Aug 18;29(36):6107-12. doi: 10.1016/j.vaccine.2011.06.076. Epub 2011 Jul 5.

3.

Anticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township.

Andersson KM, Vardas E, Niccolai LM, Van Niekerk RM, Mogale MM, Holdsworth IM, Bogoshi M, McIntyre JA, Gray GE.

Int J STD AIDS. 2012 Oct;23(10):736-41. doi: 10.1258/ijsa.2009.009378.

4.

Safer sex knowledge, behavior, and attitudes of inner-city women.

Hobfoll SE, Jackson AP, Lavin J, Britton PJ, Shepherd JB.

Health Psychol. 1993 Nov;12(6):481-8.

PMID:
8293732
5.

Modelling the impact of alternative HIV intervention strategies in rural Uganda.

Robinson NJ, Mulder DW, Auvert B, Hayes RJ.

AIDS. 1995 Nov;9(11):1263-70.

PMID:
8561980
7.

Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in Australia.

Gray RT, Ghaus MH, Hoare A, Wilson DP.

Vaccine. 2011 Aug 18;29(36):6125-9. doi: 10.1016/j.vaccine.2011.06.061. Epub 2011 Jun 22.

PMID:
21703320
8.

HIV vaccines.

Ellenberg SS, Rida WN.

Lancet. 1997 Feb 1;349(9048):361. No abstract available.

PMID:
9024406
9.

Modelling the effects of condom use and antiretroviral therapy in controlling HIV/AIDS among heterosexuals, homosexuals and bisexuals.

Malunguza N, Mushayabasa S, Chiyaka C, Mukandavire Z.

Comput Math Methods Med. 2010 Sep;11(3):201-22. doi: 10.1080/17486700903325167.

PMID:
20721763
10.

Condom use and HIV risk behaviors among U.S. adults: data from a national survey.

Anderson JE, Wilson R, Doll L, Jones TS, Barker P.

Fam Plann Perspect. 1999 Jan-Feb;31(1):24-8.

11.

Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.

Blower S, Schwartz EJ, Mills J.

AIDS Rev. 2003 Apr-Jun;5(2):113-25. Review.

PMID:
12876900
12.

Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus.

Garnett GP, Anderson RM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):500-13.

PMID:
7627626
13.
14.
15.

Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION.

Whittington WL, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL.

J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):234-8.

PMID:
16951646
16.

Predictors of African American adolescents' condom use and HIV risk behavior.

Reitman D, St Lawrence JS, Jefferson KW, Alleyne E, Brasfield TL, Shirley A.

AIDS Educ Prev. 1996 Dec;8(6):499-515.

PMID:
9010510
17.

Will sexual risk behaviour increase after being vaccinated for AIDS?

Crosby RA, Holtgrave DR.

Int J STD AIDS. 2006 Mar;17(3):180-4.

PMID:
16510006
18.

Determinants of personal demand for an AIDS vaccine in Uganda: contingent valuation survey.

Bishai D, Pariyo G, Ainsworth M, Hill K.

Bull World Health Organ. 2004 Sep;82(9):652-60.

19.
20.

Patterns of sexual behaviour and reported symptoms of STI/RTIs among young people in Croatia--implications for interventions' planning.

Bozicević I, Stulhofer A, Ajduković D, Kufrin K.

Coll Antropol. 2006 Dec;30 Suppl 2:63-70.

PMID:
17508477

Supplemental Content

Support Center